Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
In a statement to Insider, Novo Nordisk, the company that makes Wegovy and Ozempic, said that Gila monsters and the discovery of exendin-4 "did not have anything to do with our decision to develop long-acting GLP-1 receptor agonists" for obesity, because "that was based on GLP-1 biology in humans." But the company also said that "the GLP-1-like effect of exendin-4" in Gila monsters was "an important contribution to the field," as it led to the development of the very first injectable drug of its kind
The level of frustration and anger directed at this system is palpable
Krivic, A., Majerovic, M., Jelic, I., Seiwerth, S., & Sikiric, P
doi: 10.1186/s12906-020-03023-1 176
Injectable therapy ensures reliable drug delivery while maintaining affordability without membership fees or insurance requirements
US$ 20.67
US$ 26.86
US$ 26.48
US$ 20.25
